ArticleFrontiers in immunology2024

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.

Águeda Molinos-Quintana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.